<PAPER>
  <mode2 name="EHP_arathi" hasDoc="yes" version="1258"/>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="en">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
        <journal-title>Environmental Health Perspectives</journal-title>
        <abbrev-journal-title>Environ Health Perspect</abbrev-journal-title>
        <issn pub-type="epub">0091-6765</issn>
        <publisher>
          <publisher-name>National Institute of Environmental Health Sciences</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="doi">10.1289/ehp.0800208</article-id>
        <article-id pub-id-type="publisher-id">ehp-117-716</article-id>
        <article-categories>
          <subj-group>
            <subject>Research</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>
            <s sid="1">Hexavalent Chromium Is Carcinogenic to F344/N Rats and B6C3F1 Mice after Chronic Oral Exposure<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
          </article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Stout</surname>
              <given-names>Matthew D.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Herbert</surname>
              <given-names>Ronald A.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Kissling</surname>
              <given-names>Grace E.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Collins</surname>
              <given-names>Bradley J.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Travlos</surname>
              <given-names>Gregory S.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Witt</surname>
              <given-names>Kristine L.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Melnick</surname>
              <given-names>Ronald L.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Abdo</surname>
              <given-names>Kamal M.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Malarkey</surname>
              <given-names>David E.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Hooth</surname>
              <given-names>Michelle J.</given-names>
            </name>
            <xref ref-type="corresp" rid="c1-ehp-117-716"/>
          </contrib>
          <aff id="af1-ehp-117-716">
            <addr-line>National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA</addr-line>
          </aff>
        </contrib-group>
        <author-notes>
          <corresp id="c1-ehp-117-716">Address correspondence to M.J. Hooth, NIEHS, P.O. Box 12233, MD K2-13, Research Triangle Park, NC 27709 USA. Telephone: (919) 316-4643. Fax: (919) 541-4255. E-mail: <email xlink:type="simple">hooth@niehs.nih.gov</email></corresp>
          <fn>
            <p>The authors declare they have no competing financial interests.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <month>5</month>
          <year>2009</year>
        </pub-date>
        <pub-date pub-type="epub">
          <day>31</day>
          <month>12</month>
          <year>2008</year>
        </pub-date>
        <volume>117</volume>
        <issue>5</issue>
        <fpage>716</fpage>
        <lpage>722</lpage>
        <history>
          <date date-type="received">
            <day>19</day>
            <month>9</month>
            <year>2008</year>
          </date>
          <date date-type="accepted">
            <day>31</day>
            <month>12</month>
            <year>2008</year>
          </date>
        </history>
        <copyright-statement>This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <abstract>
          <sec>
            <title>Background</title>
            <p>
              <s sid="2">Hexavalent chromium [Cr(VI)] is a human carcinogen after inhalation exposure.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
              <s sid="3">Humans also ingest Cr(VI) from contaminated drinking water and soil; however, limited data exist on the oral toxicity and carcinogenicity of Cr(VI).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Objective</title>
            <p>
              <s sid="4">We characterized the chronic oral toxicity and carcinogenicity of Cr(VI) in rodents.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Methods</title>
            <p>
              <s sid="5">The National Toxicology Program (NTP) conducted 2-year drinking water studies of Cr(VI) (as sodium dichromate dihydrate) in male and female F344/N rats and B6C3F1 mice.<CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Results</title>
            <p>
              <s sid="6">Cr(VI) exposure resulted in increased incidences of rare neoplasms of the squamous epithelium that lines the oral cavity (oral mucosa and tongue) in male and female rats, and of the epithelium lining the small intestine in male and female mice.<CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
              <s sid="7">Cr(VI) exposure did not affect survival but resulted in reduced mean body weights and water consumption, due at least in part to poor palatability of the dosed water.<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
              <s sid="8">Cr(VI) exposure resulted in transient microcytic hypochromic anemia in rats and microcytosis in mice.<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/></s>
              <s sid="9">Nonneoplastic lesions included diffuse epithelial hyperplasia in the duodenum and jejunum of mice and histiocytic cell infiltration in the duodenum, liver, and mesenteric and pancreatic lymph nodes of rats and mice.<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Conclusions</title>
            <p>
              <s sid="10">Cr(VI) was carcinogenic after administration in drinking water to male and female rats and mice.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>anemia</kwd>
          <kwd>cancer</kwd>
          <kwd>hexavalent chromium</kwd>
          <kwd>histiocytic cellular infiltration</kwd>
          <kwd>National Toxicology Program</kwd>
          <kwd>oral cavity</kwd>
          <kwd>small intestine</kwd>
        </kwd-group>
      </article-meta>
    </front>
    <body>
      <p>
        <s sid="11">Hexavalent chromium [Cr(VI)] compounds are classified as human carcinogens [<xref ref-type="bibr" rid="b9-ehp-117-716">Cohen et al. 1993</xref>; <xref ref-type="bibr" rid="b23-ehp-117-716">International Agency for Research on Cancer (IARC) 1990</xref>; National Toxicology Program (NTP) 1998], based on increased incidences of lung cancers in animals and humans after inhalation exposures.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
        <s sid="12">Inhalation exposures occur primarily in occupational settings.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
        <s sid="13">The highest exposure to Cr(VI) occurs occupationally among workers involved in chrome plating, chromate production, and stainless steel welding.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="14">As a result of industrial contamination, concentrations of Cr(VI) in the drinking water and soil may be higher than concentrations resulting from natural sources alone, causing ingestion of higher concentrations by populations residing near these locations than by the general population.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
        <s sid="15">A Cr(VI) concentration of 580 &#956;g/L was found in a ground-water monitoring well in Hinkley, California (<xref ref-type="bibr" rid="b37-ehp-117-716">Pellerin and Booker 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
        <s sid="16">Detectable levels of Cr(VI) have been reported in approximately 30% of the drinking water sources monitored in California, which has a 1 &#956;g/L detection limit for purposes of reporting [<xref ref-type="bibr" rid="b6-ehp-117-716">California Department of Public Health (CDPH) 2007a</xref>]; 86% of those sources had peak concentrations of &#8804; 10 &#956;g/L.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="17">The U.S. Environmental Protection Agency (EPA) has set a maximum contaminant level of 100 &#956;g/L for total chromium in drinking water (<xref ref-type="bibr" rid="b48-ehp-117-716">U.S. EPA 2003</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
        <s sid="18">The limit in California and numerous other states is 50 &#956;g/L of total chromium in drinking water (<xref ref-type="bibr" rid="b7-ehp-117-716">CDPH 2007b</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="19">The toxicity of Cr(VI) in humans and animals has been reviewed extensively (<xref ref-type="bibr" rid="b1-ehp-117-716">Agency for Toxic Substances and Disease Registry 2000</xref>; <xref ref-type="bibr" rid="b10-ehp-117-716">Costa 1997</xref>; <xref ref-type="bibr" rid="b11-ehp-117-716">Costa and Klein 2006</xref>; <xref ref-type="bibr" rid="b49-ehp-117-716">U.S. EPA 1998</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="20">We identified only one lifetime animal carcinogenicity study in the literature in which Cr(VI) was administered in the drinking water (<xref ref-type="bibr" rid="b5-ehp-117-716">Borneff et al. 1968</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="21">Further analysis of the data (<xref ref-type="bibr" rid="b43-ehp-117-716">Sedman et al. 2006</xref>) revealed that in three generations of female NMRI mice, the combined incidences of benign and malignant forestomach neoplasms were increased over controls; this study has several limitations, including high early mortality in the F<sub>0</sub> generation as a result of ectromelia (mouse-pox) virus.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
        <s sid="22">A review of the few epidemiologic studies that evaluated populations that were exposed to Cr(VI) in drinking water or in soil or slag fill concluded that these studies did not provide definitive evidence of an increase in cancer incidence or mortality rates (<xref ref-type="bibr" rid="b40-ehp-117-716">Proctor et al. 2002</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/></s>
        <s sid="23">However, a retrospective mortality study in China found higher incidences of lung and stomach neoplasms in people living near a chromium smelting plant compared with the general population (<xref ref-type="bibr" rid="b51-ehp-117-716">Zhang and Li 1987</xref>); statistical analysis of these data supported this conclusion (<xref ref-type="bibr" rid="b3-ehp-117-716">Beaumont et al. 2008</xref>; <xref ref-type="bibr" rid="b43-ehp-117-716">Sedman et al. 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="24">Because of concerns over its presence in drinking water source supplies, its potential health effects, including carcinogenicity, and the lack of adequate carcinogenicity studies by the oral route, the California Congressional Delegation, California Environmental Protection Agency, and California Department of Health Services nominated Cr(VI) to the NTP for toxicity and carcinogenicity testing.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/></s>
        <s sid="25">We selected sodium dichromate dihydrate (SDD) for testing because it is the primary base material for the production of chromium compounds, is widely used in industrial applications, and is the most water-soluble chromate.<CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="26">The NTP previously conducted 3-month toxicity studies of SDD administered in drinking water (<xref ref-type="bibr" rid="b33-ehp-117-716">NTP 2007</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
        <s sid="27">F344/N rats and B6C3F1 mice were exposed to 0, 62.5, 125, 250, 500, or 1,000 mg SDD/L.<CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
        <s sid="28">In these studies, both rats and mice had reduced body weight and water consumption and microcytic hypochromic anemia; the anemia was more severe in rats.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/></s>
        <s sid="29">Exposure-related histopathologic lesions included ulcers, epithelial hyper plasia, and squamous metaplasia in the glandular stomach of rats; epithelial hyperplasia of the duodenum of mice; and histiocytic cellular infiltration in the liver, duodenum, and pancreatic lymph node of rats and in the duodenum and mesenteric lymph node of mice.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="30">We selected exposure concentrations for the 2-year studies of SDD after review of the 3-month toxicity study data.<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/></s>
        <s sid="31">The highest exposure concentration for the 2-year studies in rats and mice was limited by toxicity observed in the 3-month studies (<xref ref-type="bibr" rid="b33-ehp-117-716">NTP 2007</xref>), and a wider spacing of exposure concentrations was selected to extend the dose&#8211;response curve.<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
        <s sid="32">We added an additional low-exposure group [5 mg Cr(VI)/L] to the 2-year studies to provide a concentration closer to human exposure through contaminated drinking water.<CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="None" advantage="None"/></s>
        <s sid="33">In this report we present the primary findings of the NTP chronic oral toxicity and carcinogenesis studies of Cr(VI) in male and female rats and mice; a more detailed report on these studies is available as an NTP technical report (<xref ref-type="bibr" rid="b34-ehp-117-716">NTP 2008a</xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
      </p>
      <sec sec-type="materials|methods">
        <title>Materials and Methods</title>
        <sec sec-type="display-objects">
          <title>Figure and Tables</title>
          <fig id="f1-ehp-117-716" position="float">
            <label>Figure 1</label>
            <caption>
              <p>(<italic>A</italic> and <italic>B</italic>) Male rat given 516 mg/L SDD for 2 years. (<italic>A</italic>) Low magnification of a section of the nasal cavity demonstrating the location of squamous cell carcinoma (arrows) arising from the oral mucosa of the soft palate; the neoplasm has invaded the adjacent submucosal tissue and surrounded a molar tooth. (<italic>B</italic>) Higher magnification demonstrating the malignant features of the squamous cell carcinoma; islands and cords of dysplastic squamous epithelium (arrows) are surrounded by dense proliferative connective tissue stroma. (<italic>C</italic>) Female rat given 14.3 mg/L SDD for 2 years; squamous cell carcinoma projects from the dorsal mucosal surface of the tongue (arrows). (<italic>D</italic>) Female mouse given 516 mg/L SDD for 2 years; adenoma of the duodenum (arrows) has distorted and replaced a segment of the mucosa and protruded into the lumen. Normal mucosa is visible opposite the adenoma. (<italic>E</italic>) Male mouse given 257.4 mg/L SDD for 2 years; carcinoma of the duodenum (arrows) has effaced the mucosa, invading the submucosa, muscle layers, and pancreas. (<italic>F</italic>) Male mouse given 172 mg/L SDD for 2 years; focal hyperplasia of the duodenum (arrows) is present in the superficial mucosa. (<italic>G</italic>) Control female mouse; duodenum demonstrates normal microscopic anatomy. Note tall, slender villi (arrows) lined by a single layer of tall columnar epithelial cells. (<italic>H</italic>) Female mouse given 516 mg/L SDD for 2 years; diffuse hyperplasia is present in the duodenum. Duodenal villi are short, wide, and blunt and lined by hyperplastic epithelial cells that are piling up along the villi (arrows). Note histiocyte infiltrates expanding the lamina propria at the tips of the villi (asterisks). All sections are stained with hematoxylin and eosin. Bars: A and C, 500 &#956;m; B and F, 100 &#956;m; D and E, 200 &#956;m; G and H, 50 &#956;m.</p>
            </caption>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800208.g001" xlink:type="simple"/>
          </fig>
          <table-wrap id="t1-ehp-117-716" position="float">
            <label>Table 1</label>
            <caption>
              <p>Concentrations in drinking water and average daily ingested doses of SDD and Cr(VI) after exposure for 2 years.</p>
            </caption>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800208.t001" xlink:type="simple"/>
          </table-wrap>
          <table-wrap id="t2-ehp-117-716" position="float">
            <label>Table 2</label>
            <caption>
              <p>Squamous cell neoplasms of the oral cavity (oral mucosa and tongue) of F344/N rats exposed to SDD for 2 years in drinking water.</p>
            </caption>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800208.t002" xlink:type="simple"/>
          </table-wrap>
          <table-wrap id="t3-ehp-117-716" position="float">
            <label>Table 3</label>
            <caption>
              <p>Epithelial neoplasms of the small intestine in B6C3F1 mice exposed to SDD in drinking water for 2 years.</p>
            </caption>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800208.t003" xlink:type="simple"/>
          </table-wrap>
          <table-wrap id="t4-ehp-117-716" position="float">
            <label>Table 4</label>
            <caption>
              <p>Focal and diffuse hyperplasia of the small intestine in B6C3F1 mice exposed to SDD in drinking water for 2 years.</p>
            </caption>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.0800208.t004" xlink:type="simple"/>
          </table-wrap>
        </sec>
        <sec>
          <title>Chemical and dose formulations</title>
          <p>
            <s sid="34">SDD (CAS 7789-12-0) was obtained from Aldrich Chemical Company (Milwaukee, WI).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
            <s sid="35">The purity was determined using differential scanning calorimetry, titration of the dichromate ion with sodium thiosulfate and potassium ferrocyanide, speciation of the chromium ions using liquid chromatography/inductively coupled plasma-mass spectrometry, and potentiometric titrimetric analysis with sodium thiosulfate.<CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="None" advantage="None"/></s>
            <s sid="36">Based on these analyses, the overall purity was &#8805; 99.7%.<CoreSc1 atype="GSC" type="Met" conceptID="Met9" novelty="None" advantage="None"/></s>
            <s sid="37">The dose formulations were prepared approximately every 2 weeks by mixing SDD with tap water and stored at room temperature in sealed containers protected from light.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
            <s sid="38">The dose formulations were stable for 42 days under these conditions.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
            <s sid="39">Periodic analysis by ultraviolet spectroscopy with detection at 350&#8211;390 nm confirmed that all dose formulations varied by &lt; 10% of the target concentrations.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Animals and animal maintenance</title>
          <p>
            <s sid="40">The studies were conducted at Southern Research Institute (Birmingham, AL).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
            <s sid="41">Male and female F344/N rats and B6C3F1 mice were obtained from Taconic Farms (Germantown, NY).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
            <s sid="42">Rats and mice were quarantined for 14 days, and were 6&#8211;7 weeks of age at the beginning of the studies.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
            <s sid="43">Animals were distributed randomly into groups of approximately equal initial mean body weights and identified by tail tattoo.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/></s>
            <s sid="44">Rats and mice were housed one (male mice), three (male rats), or five (female rats and mice) to a cage.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/></s>
            <s sid="45">Feed (irradiated NTP-2000 wafers; Zeigler Brothers, Inc., Gardners, PA) and tap water were available <italic>ad libitum</italic>.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/></s>
            <s sid="46">Animals were killed by carbon dioxide asphyxiation.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="47">Animal use was in accordance with the U.S. Public Health Service policy on humane care and use of laboratory animals and the <italic>Guide for the Care and Use of Laboratory Animals</italic> (<xref ref-type="bibr" rid="b29-ehp-117-716">National Research Council 1996</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/></s>
            <s sid="48">Animals were treated humanely and with regard for alleviation of suffering.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/></s>
            <s sid="49">These studies were conducted in compliance with the Food and Drug Administration Good Laboratory Practice Regulations (<xref ref-type="bibr" rid="b22-ehp-117-716">Food and Drug Administration 1987</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Study design</title>
          <p>
            <s sid="50">Groups of 50 male and 50 female rats and mice were exposed to SDD in drinking water at concentrations of 0, 14.3, 57.3, 172, or 516 mg/L (male and female rats and female mice) or 0, 14.3, 28.6, 85.7, or 257.4 mg/L (male mice) for 105&#8211;106 weeks.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/></s>
            <s sid="51"><xref ref-type="table" rid="t1-ehp-117-716">Table 1</xref> shows corresponding Cr(VI) concentrations.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/></s>
            <s sid="52">Water consumption was recorded weekly for the first 13 weeks and every 4 weeks thereafter, with each water consumption measurement covering a 7-day period.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/></s>
            <s sid="53">Animals were weighed initially, weekly for the first 13 weeks, at 4-week intervals thereafter, and at the end of the studies.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/></s>
            <s sid="54">Animals were observed twice daily and clinical findings were recorded at 4-week intervals beginning at week 5.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="55">Complete necropsies and microscopic examinations were performed on all core study rats and mice.<CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="None" advantage="None"/></s>
            <s sid="56">At necropsy, all organs and tissues were examined for grossly visible lesions, and all protocol-required tissues were fixed and preserved in 10% neutral buffered formalin (eyes were initially fixed in Davidson&#8217;s solution), trimmed and processed, embedded in paraffin, sectioned to a thickness of 4&#8211;6 &#956;m, and stained with hematoxylin and eosin (H&amp;E) for microscopic examination.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/></s>
            <s sid="57">For all paired organs (e.g., adrenal gland, kidney, ovary), samples from each organ were examined.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/></s>
            <s sid="58">The entire gastrointestinal tract was opened and potential lesions were collected for microscopic evaluation.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/></s>
            <s sid="59">Oral mucosa and tongue are not protocol-required tissues; however, because gross lesions in these tissues were diagnosed as neoplasms, the oral mucosa and tongue of all animals were evaluated histologically.<CoreSc1 atype="GSC" type="Met" conceptID="Met11" novelty="None" advantage="None"/></s>
            <s sid="60">Additional details regarding the pathology data generation, quality assurance review, and NTP pathology working group are available in the NTP technical report (<xref ref-type="bibr" rid="b34-ehp-117-716">NTP 2008a</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="None" advantage="None"/></s>
            <s sid="61">Details of these review procedures have been described, in part, by <xref ref-type="bibr" rid="b26-ehp-117-716">Maronpot and Boorman (1982)</xref> and <xref ref-type="bibr" rid="b4-ehp-117-716">Boorman et al. (1985)</xref>.<CoreSc1 atype="GSC" type="Met" conceptID="Met13" novelty="None" advantage="None"/></s>
            <s sid="62">For subsequent analyses of the pathology data, the decision of whether to evaluate the diagnosed lesions for each tissue type separately or combined was based on the guidelines of <xref ref-type="bibr" rid="b27-ehp-117-716">McConnell et al. (1986)</xref>.<CoreSc1 atype="GSC" type="Met" conceptID="Met14" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="63">Hematology and clinical chemistry were evaluated in additional groups of 10&#8211;16 male rats and female mice on days 4 (male rats only) and 22 and at 3, 6, and 12 months.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/></s>
            <s sid="64">At these time points, rats and mice were anesthetized with CO<sub>2</sub>/O<sub>2</sub>, and blood was taken from the retroorbital sinus.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Statistical methods</title>
          <p>
            <s sid="65">We estimated the probability of survival by the product-limit procedure of <xref ref-type="bibr" rid="b25-ehp-117-716">Kaplan and Meier (1958)</xref>.<CoreSc1 atype="GSC" type="Met" conceptID="Met15" novelty="None" advantage="None"/></s>
            <s sid="66">Animals found dead of other than natural causes or missing were censored from the survival analyses; animals dying from natural causes were not censored.<CoreSc1 atype="GSC" type="Met" conceptID="Met16" novelty="None" advantage="None"/></s>
            <s sid="67">Statistical analyses for possible dose-related effects on survival used <xref ref-type="bibr" rid="b12-ehp-117-716">Cox&#8217;s (1972)</xref> method for testing two groups for equality and <xref ref-type="bibr" rid="b47-ehp-117-716">Tarone&#8217;s (1975)</xref> life table test to identify dose-related trends.<CoreSc1 atype="GSC" type="Met" conceptID="Met17" novelty="None" advantage="None"/></s>
            <s sid="68">All reported <italic>p</italic>-values for the survival analyses are two sided.<CoreSc1 atype="GSC" type="Met" conceptID="Met18" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="69">We used the poly-<italic>k</italic> test (<xref ref-type="bibr" rid="b2-ehp-117-716">Bailer and Portier 1988</xref>; <xref ref-type="bibr" rid="b38-ehp-117-716">Piegorsch and Bailer 1997</xref>; <xref ref-type="bibr" rid="b39-ehp-117-716">Portier and Bailer 1989</xref>) to assess neoplasm and nonneoplastic lesion incidence.<CoreSc1 atype="GSC" type="Met" conceptID="Met19" novelty="None" advantage="None"/></s>
            <s sid="70">This test is a survival-adjusted quantal-response procedure that modifies the Cochran-Armitage linear trend test to take survival differences into account; we used a value of <italic>k</italic> = 3 in the analysis of site-specific lesions.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/></s>
            <s sid="71">Tests of significance included pairwise comparisons of each exposed group with controls and a test for an overall exposure-related trend.<CoreSc1 atype="GSC" type="Met" conceptID="Met20" novelty="None" advantage="None"/></s>
            <s sid="72">We used continuity-corrected poly-3 tests in the analysis of lesion incidence, and reported <italic>p</italic>-values are one sided.<CoreSc1 atype="GSC" type="Met" conceptID="Met21" novelty="None" advantage="None"/></s>
            <s sid="73">Sub- and supralinear trends across doses for intestinal tumor rates were assessed with lack-of-fit tests for the linear regression of intestinal tumor rate on dose (<xref ref-type="bibr" rid="b30-ehp-117-716">Neter et al. 1996</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met22" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="74">We analyzed hematology and clinical chemistry data, which typically have skewed distributions, using the modified (<xref ref-type="bibr" rid="b19-ehp-117-716">Dunn 1964</xref>; <xref ref-type="bibr" rid="b50-ehp-117-716">Williams 1986</xref>) nonparametric multiple comparison methods of <xref ref-type="bibr" rid="b45-ehp-117-716">Shirley (1977)</xref>.<CoreSc1 atype="GSC" type="Met" conceptID="Met23" novelty="None" advantage="None"/></s>
            <s sid="75">We used Jonckheere&#8217;s test (<xref ref-type="bibr" rid="b24-ehp-117-716">Jonckheere 1954</xref>) to assess the significance of the dose-related trends and to determine whether a trend-sensitive test (<xref ref-type="bibr" rid="b45-ehp-117-716">Shirley 1977</xref>; <xref ref-type="bibr" rid="b50-ehp-117-716">Williams 1986</xref>) was more appropriate for pairwise comparisons than a test that does not assume a monotonic dose-related trend (<xref ref-type="bibr" rid="b19-ehp-117-716">Dunn 1964</xref>; <xref ref-type="bibr" rid="b20-ehp-117-716">Dunnett 1955</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met24" novelty="None" advantage="None"/></s>
            <s sid="76">Before statistical analysis, we examined extreme values identified by the outlier test of <xref ref-type="bibr" rid="b17-ehp-117-716">Dixon and Massey (1957)</xref> and eliminated implausible values from the analysis.<CoreSc1 atype="GSC" type="Met" conceptID="Met25" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <sec>
          <title>Oral cavity neoplasms in rats</title>
          <p>
            <s sid="77">Male and female rats showed significantly increased incidences of highly aggressive neoplasms of the squamous epithelium that lines the oral cavity (oral mucosa and tongue) at 516 mg/L (<xref ref-type="table" rid="t2-ehp-117-716">Table 2</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/></s>
            <s sid="78">Specifically, we observed increases for squamous cell carcinoma in the oral mucosa and for squamous cell papilloma or carcinoma (combined) of the oral mucosa or tongue of male and female rats at 516 mg/L.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
            <s sid="79">There were squamous cell carcinomas in the oral mucosa of two 172 mg/L female rats; this incidence exceeded the historical control ranges for drinking water studies and for all routes of administration (<xref ref-type="table" rid="t2-ehp-117-716">Table 2</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
            <s sid="80">We did not observe nonneoplastic lesions in the oral mucosa.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="81">Microscopically, the squamous cell carcinomas were highly invasive, irregular masses.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/></s>
            <s sid="82">Typically, the carcinomas appeared to originate in the oral mucosa of the palate adjacent to the upper molar teeth (<xref ref-type="fig" rid="f1-ehp-117-716">Figure 1A, B</xref>); in some animals they invaded the tongue, Harderian gland, and the soft tissues surrounding the nose, and in one case it penetrated the maxilla and invaded the brain.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/></s>
            <s sid="83">The squamous cell papillomas of the oral mucosa and tongue were exophytic masses that projected from the mucosa and consisted of irregular papillary proliferations of mature squamous epithelium supported by a core of fibrovascular stroma (<xref ref-type="fig" rid="f1-ehp-117-716">Figure 1C</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Small intestine neoplasms and hyperplasia in mice</title>
          <p>
            <s sid="84">Both males and females showed a clear exposure concentration response for increased incidences of adenoma or carcinoma (combined) at all sites (combined) of the small intestine (duodenum, jejunum, or ileum; <xref ref-type="table" rid="t3-ehp-117-716">Table 3</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/></s>
            <s sid="85">These increases were significant at 85.7 and 257.4 mg/L in males and at 172 and 516 mg/L females, the two highest exposure concentrations in each sex.<CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/></s>
            <s sid="86">In addition, the incidence in 57.3 mg/L females exceeded the historical control ranges for drinking water studies and for all routes of administration (<xref ref-type="table" rid="t3-ehp-117-716">Table 3</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/></s>
            <s sid="87">These increases were driven primarily by significant increases in the incidences of adenoma of the duodenum in 257.4 mg/L males and in 172 and 516 mg/L females; the number of mice with multiple adenomas was also significantly increased at the high dose in both sexes (data not shown).<CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/></s>
            <s sid="88">In females, the incidence of carcinoma in the duodenum was significantly increased at 516 mg/L.<CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/></s>
            <s sid="89">In the jejunum, the incidence of adenoma was increased in 516 mg/L females.<CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/></s>
            <s sid="90">For both males and females, we tested the combined incidence of adenoma and carcinoma for departures from a linear dose response (data not shown).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp26" novelty="None" advantage="None"/></s>
            <s sid="91">For males, the trend was linear, with no significant departure from linearity.<CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/></s>
            <s sid="92">For females, the response was supralinear with a significant departure from linearity.<CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="93">Adenomas were discrete, broad based, focally extensive, plaquelike areas of proliferating glandular epithelium that thickened the mucosa and protruded into the lumen (<xref ref-type="fig" rid="f1-ehp-117-716">Figure 1D</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/></s>
            <s sid="94">Carcinomas were sessile, plaque-like neoplasms distinguished from adenomas by extensive invasion and effacement of the mucosa, underlying submucosa, and muscle layers (<xref ref-type="fig" rid="f1-ehp-117-716">Figure 1E</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="95">Low incidences of focal epithelial hyperplasia occurred in the duodenum of exposed male and female mice (<xref ref-type="table" rid="t4-ehp-117-716">Table 4</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/></s>
            <s sid="96">Although the increased incidences were not exposure concentration related or statistically significant, we considered this lesion a preneoplastic lesion related to exposure to SDD because of its morphologic similarities to adenoma.<CoreSc1 atype="GSC" type="Res" conceptID="Res14" novelty="None" advantage="None"/></s>
            <s sid="97">Focal epithelial hyperplasias were focal areas of proliferating glandular epithelium distinguished from adenomas because they were smaller, less discrete, and confined to the superficial mucosal epithelium (<xref ref-type="fig" rid="f1-ehp-117-716">Figure 1F</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="98">The incidences of diffuse epithelial hyperplasia were significantly increased in the duodenum of all exposed groups of male and female mice (<xref ref-type="table" rid="t4-ehp-117-716">Table 4</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res15" novelty="None" advantage="None"/></s>
            <s sid="99">In the jejunum, the incidence of diffuse epithelial hyperplasia was significantly increased in 516 mg/L females.<CoreSc1 atype="GSC" type="Res" conceptID="Res16" novelty="None" advantage="None"/></s>
            <s sid="100">In contrast to those of the controls (<xref ref-type="fig" rid="f1-ehp-117-716">Figure 1G</xref>), the duodenums of exposed mice had short, broad, blunt villi and generalized mucosal hypercellularity that was particularly prominent in the villi (<xref ref-type="fig" rid="f1-ehp-117-716">Figure 1H</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res17" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Histiocytic infiltration in rats and mice</title>
          <p>
            <s sid="101">We found significant increases in histiocytic cell infiltration in the duodenum and mesenteric lymph node of rats and mice of both sexes, in the jejunum of female mice, in the liver of male and female rats and female mice, and in the pancreatic lymph node of female rats and male and female mice; these data are presented in detail in the NTP technical report (<xref ref-type="bibr" rid="b34-ehp-117-716">NTP 2008a</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res18" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="102">The infiltrating histiocytes were morphologically similar in tissues of rats and mice.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/></s>
            <s sid="103">Histiocytic infiltrates were characterized by the presence of individual, small clusters, and sometimes syncytia of large histiocytes (macrophages) within the sinusoids of the liver and lymph nodes and the lamina propria at the tips of the duodenal and jejunal villi.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs12" novelty="None" advantage="None"/></s>
            <s sid="104">In the lymph nodes, the histiocytic infiltrates occurred as expansive sheets that in some cases replaced much of the lymph node parenchyma.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/></s>
            <s sid="105">The biological significance and cause of the histiocytic cellular infiltrates are unknown.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot4" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Hematology in rats and mice</title>
          <p>
            <s sid="106">In rats, an exposure-related decrease in mean cell volumes, mean cell hemoglobin concentrations, hematocrits, hemoglobin concentrations, and erythrocyte counts and increase in reticulocyte counts were indicative of erythrocyte microcytic, hypochromic, responsive anemia; these data are presented in detail in the NTP technical report (<xref ref-type="bibr" rid="b34-ehp-117-716">NTP 2008a</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res19" novelty="None" advantage="None"/></s>
            <s sid="107">The anemia was most prominent early in the study (22 days to 3 months).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/></s>
            <s sid="108">Microscopic evaluations of blood smears demonstrated increased poikilocytes, erythrocyte fragments/schizocytes, keratocytes, erythrocyte hypochromia, and microcytes that suggested increased erythrocyte injury or turnover.Microscopic evaluations of blood smears demonstrated increased poikilocytes, erythrocyte fragments/schizocytes, keratocytes, erythrocyte hypochromia, and microcytes that suggested increased erythrocyte injury or turnover.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/></s>
            <s sid="109">This effect was more prominent on day 22 and at 3 months than at 6 or 12 months, which may have been either a result of the animals adapting to exposure or a result of the decreased Cr(IV) ingestion per unit body weight with longer exposure durations.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs16" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Res" conceptID="Res20" novelty="None" advantage="None"/></s>
            <s sid="110">Mice demonstrated a similar, but less severe, effect on erythron.<CoreSc1 atype="GSC" type="Res" conceptID="Res21" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>In life effects in rats and mice</title>
          <p>
            <s sid="111">Survival, body weight, and water consumption data are presented in detail in the NTP technical report (<xref ref-type="bibr" rid="b34-ehp-117-716">NTP 2008a</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res22" novelty="None" advantage="None"/></s>
            <s sid="112">Survival of exposed groups of male and female rats and mice was similar to that of the respective control groups.<CoreSc1 atype="GSC" type="Res" conceptID="Res23" novelty="None" advantage="None"/></s>
            <s sid="113">Mean body weights compared with controls were decreased in male and female rats and mice.<CoreSc1 atype="GSC" type="Res" conceptID="Res24" novelty="None" advantage="None"/></s>
            <s sid="114">In rats, mean body weights of 516 mg/L males and females were less than those of controls throughout the study and by the end of the study were 12% (males) or 11% (females) less than the controls.<CoreSc1 atype="GSC" type="Res" conceptID="Res25" novelty="None" advantage="None"/></s>
            <s sid="115">Mean body weights of 257.4 mg/L male mice were less than controls for the first 4 months of the study but were only slightly less (6%) by the end of the study.<CoreSc1 atype="GSC" type="Res" conceptID="Res26" novelty="None" advantage="None"/></s>
            <s sid="116">Mean body weights were less than the controls from months 3 to 12 in 172 mg/L female mice and from month 2 until the end of the study in 516 mg/L females.<CoreSc1 atype="GSC" type="Res" conceptID="Res27" novelty="None" advantage="None"/></s>
            <s sid="117">By the end of the study, mean body weights were &lt; 8% of controls in 172 mg/L females and 15% less in 516 mg/L females.<CoreSc1 atype="GSC" type="Res" conceptID="Res28" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="118">We attributed the lower body weights partly to poor palatability of the dosed water and consequent reductions in water consumption rather than direct toxic effects of SDD exposure.<CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
            <s sid="119">Water consumption by male and female rats and mice exposed to the two highest concentrations was that by the controls throughout the study.<CoreSc1 atype="GSC" type="Res" conceptID="Res29" novelty="None" advantage="None"/></s>
            <s sid="120">No clinical findings were attributed to SDD exposure in rats or mice.<CoreSc1 atype="GSC" type="Res" conceptID="Res30" novelty="None" advantage="None"/></s>
            <s sid="121">When we adjusted water consumption for body weight (data not shown), dosed male and female rats and female mice drank approximately the same quantities of water per gram of body weight as did the controls after the first 20 weeks on study.<CoreSc1 atype="GSC" type="Res" conceptID="Res31" novelty="None" advantage="None"/></s>
            <s sid="122">Male mice exposed to 257.4 mg/L drank less water per gram of body weight than did the controls throughout the study.<CoreSc1 atype="GSC" type="Res" conceptID="Res32" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>
          <s sid="123">Humans are exposed to Cr(VI) through ingestion of contaminated water and soil; however, few data exist on the oral toxicity and carcinogenicity of Cr(VI).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/></s>
          <s sid="124">The NTP conducted 3-month (<xref ref-type="bibr" rid="b33-ehp-117-716">NTP 2007</xref>) and 2-year (<xref ref-type="bibr" rid="b34-ehp-117-716">NTP 2008a</xref>) studies of SDD administered in the drinking water to F344/N rats and B6C3F1 mice, to provide data on the potential for toxic and carcinogenic effects after ingestion of Cr(VI).<CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met26" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="125">Chronic administration of SDD in drinking water did not affect survival or produce clinical signs of toxicity in rats or mice.<CoreSc1 atype="GSC" type="Res" conceptID="Res33" novelty="None" advantage="None"/></s>
          <s sid="126">We observed exposure-related reductions in body weight gain and water consumption for rats and mice in the highest exposure groups and attributed these changes partly to poor palatability of the dosed water.<CoreSc1 atype="GSC" type="Res" conceptID="Res34" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/></s>
          <s sid="127">Several lines of evidence suggest that the animals were not dehydrated, including analysis of the water consumption data normalized to body weight and the complete lack of clinical observations or hematologic or clinical chemistry effects (<xref ref-type="bibr" rid="b34-ehp-117-716">NTP 2008a</xref>) that typically indicate dehydration.<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="128">The NTP concluded that the exposure concentration-related significant increases in epithelial neoplasms of the upper alimentary tract (oral cavity) in male and female rats and of the lower alimentary tract (small intestine) in male and female mice provided clear evidence of carcinogenic activity of SDD in male and female rats and mice.<CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
          <s sid="129">We based this conclusion on the increased neoplasm incidences relative to concurrent controls and the rarity of these neoplasms (<xref ref-type="table" rid="t2-ehp-117-716">Tables 2</xref> and <xref ref-type="table" rid="t3-ehp-117-716">3</xref>) in historical controls.<CoreSc1 atype="GSC" type="Res" conceptID="Res35" novelty="None" advantage="None"/></s>
          <s sid="130">In both rats and mice, this conclusion was strengthened by similarities between the sexes.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/></s>
          <s sid="131">We observed no increases in nonneoplastic histopathologic lesions in either species suggestive of overt tissue damage due to the oxidant properties of Cr(VI).<CoreSc1 atype="GSC" type="Res" conceptID="Res36" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="132">We observed obvious species differences in the target tissues for the development of neoplasms between rats and mice.<CoreSc1 atype="GSC" type="Res" conceptID="Res37" novelty="None" advantage="None"/></s>
          <s sid="133">Of the 21 chemicals that have caused neoplasms of the oral cavity in NTP studies, none produced these neoplasms in male mice and only one, 1,2,3-trichloropropane (<xref ref-type="bibr" rid="b31-ehp-117-716">NTP 1993</xref>), produced oral cavity neoplasms in female mice, demonstrating a greater sensitivity to the development of oral cavity neoplasms in rats relative to mice.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/></s>
          <s sid="134">Although slightly more common in rats, exposure-related increases of small intestine neoplasms in NTP studies are relatively rare in both species.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/></s>
          <s sid="135">The 2-year study of captan (<xref ref-type="bibr" rid="b28-ehp-117-716">National Cancer Institute 1977</xref>) is the only other study performed by the NTP in B6C3F1 mice in which both benign and malignant intestinal neoplasms of epithelial origin have been definitely attributed to chemical exposure (<xref ref-type="bibr" rid="b44-ehp-117-716">Shackelford and Elwell 1999</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="136">Although the induction of neoplasms after exposure to SDD was limited to the alimentary tract, other data, including the toxicity to the erythron, provided evidence of systemic exposure and toxicity in male and female rats and mice exposed to Cr(VI) for 2 years.<CoreSc1 atype="GSC" type="Res" conceptID="Res38" novelty="None" advantage="None"/></s>
          <s sid="137">We also observed these lesions in the 3-month studies (<xref ref-type="bibr" rid="b33-ehp-117-716">NTP 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="138">As part of the NTP 2-year studies on SDD (<xref ref-type="bibr" rid="b34-ehp-117-716">NTP 2008a</xref>) and chromium picolinate monohydrate (CPM) (<xref ref-type="bibr" rid="b35-ehp-117-716">NTP 2008b</xref>), which contains trivalent chromium [Cr(III)], total chromium content was determined in selected tissues and excreta of additional groups of male rats and female mice; these data will be presented in detail in an additional report.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/></s>
          <s sid="139">The goal of these studies was to examine the tissue uptake and distribution of Cr(VI) and Cr(III).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/></s>
          <s sid="140">Because Cr(VI) is reduced to Cr(III) both intracellularly and extracellularly and because analytical methods for the separate analysis of Cr(VI) or Cr(III) in biological samples are not available, the speciation of the tissue chromium after exposure to Cr(VI) was inferred by comparing total chromium concentrations in tissues of rats and mice exposed to similar doses of Cr(VI) or Cr(III).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/></s>
          <s sid="141">After oral exposure to Cr(VI), chromium accumulation was correlated with exposure concentration and duration in several tissues (<xref ref-type="bibr" rid="b34-ehp-117-716">NTP 2008a</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res39" novelty="None" advantage="None"/></s>
          <s sid="142">Similar doses of Cr(VI) and Cr(III) resulted in significantly higher tissue chromium concentrations with Cr(VI), indicating that chromium was absorbed and distributed to tissues of rats and mice as Cr(VI); these data are consistent with previous studies (<xref ref-type="bibr" rid="b10-ehp-117-716">Costa 1997</xref>; <xref ref-type="bibr" rid="b11-ehp-117-716">Costa and Klein 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac23" novelty="None" advantage="None"/></s>
          <s sid="143">The tissue concentration data were consistent with linear or supralinear (decreasing rate of response with increasing dose) dose responses.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac24" novelty="None" advantage="None"/></s>
          <s sid="144">In the present studies, neither the oral cavity nor the small intestine was collected for total chromium analysis.<CoreSc1 atype="GSC" type="Met" conceptID="Met27" novelty="None" advantage="None"/></s>
          <s sid="145">However, other reports suggest that Cr(VI) is also likely to be absorbed in the small intestine to a greater extent than Cr(III) (<xref ref-type="bibr" rid="b18-ehp-117-716">Donaldson and Barreras 1966</xref>; <xref ref-type="bibr" rid="b21-ehp-117-716">Febel et al. 2001</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac25" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="146">Reduction of Cr(VI) to the less permeable and bioavailable Cr(III) is thought to occur primarily in the stomach, as a mechanism of detoxification.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac26" novelty="None" advantage="None"/></s>
          <s sid="147">Gastric reduction has been hypothesized to be efficient, such that oral exposure to Cr(VI) would not result in toxicity or carcinogenicity, except perhaps in the stomach (<xref ref-type="bibr" rid="b13-ehp-117-716">De Flora 2000</xref>; <xref ref-type="bibr" rid="b15-ehp-117-716">De Flora et al. 1997</xref>; <xref ref-type="bibr" rid="b40-ehp-117-716">Proctor et al. 2002</xref>).<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/></s>
          <s sid="148">Notably, in the 2-year study, no neoplasms or nonneoplastic lesions were observed in the forestomach or glandular stomach of rats or mice.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac27" novelty="None" advantage="None"/></s>
          <s sid="149">However, the observed increases in neoplasms of the small intestine of mice and the toxicity to the erythron, histiocytic infiltration, and uptake of Cr(IV) into tissues of rats and mice suggest that, under the conditions of this study, at least a portion of the administered Cr(VI) was not reduced in the stomach.<CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/></s>
          <s sid="150">The significant disparity in the oral toxicity and carcinogenicity of Cr(VI) and Cr(III) in rodents, including the absence of increases in neoplasms or nonneoplastic lesions of the small intestine in rats or mice exposed to CPM (<xref ref-type="bibr" rid="b35-ehp-117-716">NTP 2008b</xref>), provides additional evidence that Cr(VI) is not completely reduced in the stomach and is responsible for the observed effects.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac28" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="151">Recently, <xref ref-type="bibr" rid="b16-ehp-117-716">De Flora et al. (2008)</xref> have suggested that increases in neoplasms of the small intestine observed in mice in the present study are the result of saturation of the gastric reduction capacity.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac29" novelty="None" advantage="None"/></s>
          <s sid="152">If such a threshold mechanism were to occur, the dose that saturated the reducing capacity would likely represent an inflection point on a sublinear dose response curve, with doses above the inflection point demonstrating an increasing rate of response per unit dose, because unreduced chromium would be transported into tissues.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/></s>
          <s sid="153">However, when we tested tissue concentration and mouse small intestine neoplasm data for linearity, data that were statistically nonlinear were supralinear (decreasing rate of response per unit dose).<CoreSc1 atype="GSC" type="Res" conceptID="Res40" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="154">A reduction capacity of about 84&#8211;88 mg Cr(VI)/day has been estimated for human gastric juice (<xref ref-type="bibr" rid="b15-ehp-117-716">De Flora et al. 1997</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac30" novelty="None" advantage="None"/></s>
          <s sid="155">This estimate was based on reported values of human secretion of gastric fluid per day during fasting and after consuming three meals per day in combination with experimental data on reduction of Cr(VI)/mL of gastric juice produced during these periods.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac31" novelty="None" advantage="None"/></s>
          <s sid="156">Similar data are not available for Cr(VI) reduction by mouse gastric juice.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac32" novelty="None" advantage="None"/></s>
          <s sid="157">However, assuming that Cr(VI) reduction is equally effective in mice and humans and that gastric secretion scales across species by body weight<sup>3/4</sup>, then the Cr(VI) reduction capacity of gastric juice from a 50-g mouse would be approximately 0.4 mg/day (~ 8 mg/kg/day).<CoreSc1 atype="GSC" type="Con" conceptID="Con9" novelty="None" advantage="None"/></s>
          <s sid="158">This value is greater than all of the male mouse doses and is nearly equivalent to the average daily dose of Cr(VI) in the high-dose group of female mice in the 2-year drinking water study of SDD (<xref ref-type="table" rid="t1-ehp-117-716">Table 1</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs17" novelty="None" advantage="None"/></s>
          <s sid="159">Collectively, the dose&#8211;response analysis and gastric reduction capacity calculations indicate that SDD induced neoplasms in the small intestine of mice at dose levels that did not exceed the estimated Cr(VI) reducing capacity for gastric juices in mice.<CoreSc1 atype="GSC" type="Con" conceptID="Con10" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="160">Cr(VI) is genotoxic in a number of <italic>in vitro</italic> and <italic>in vivo</italic> test systems (<xref ref-type="bibr" rid="b14-ehp-117-716">De Flora et al. 1990</xref>; <xref ref-type="bibr" rid="b23-ehp-117-716">IARC 1990</xref>); however, the mechanisms of genotoxicity and carcinogenicity are not fully understood.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot5" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Obj" conceptID="Obj4" novelty="None" advantage="None"/></s>
          <s sid="161">Because Cr(VI) as chromate structurally resembles sulfate and phosphate, it can be taken up by all cells and organs throughout the body through non-specific anion transporters (<xref ref-type="bibr" rid="b10-ehp-117-716">Costa 1997</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac33" novelty="None" advantage="None"/></s>
          <s sid="162">Once inside the cell, indirect DNA damage may occur through the generation of oxygen radicals during intracellular reduction of Cr(VI) through the more reactive pentavalent and tetravalent chromium to Cr(III) (<xref ref-type="bibr" rid="b36-ehp-117-716">O&#8217;Brien et al. 2003</xref>); however, evidence of the role of reactive oxygen species in the genotoxicity of Cr(VI) is inconsistent (<xref ref-type="bibr" rid="b8-ehp-117-716">Chorvatovicova et al. 1991</xref>; <xref ref-type="bibr" rid="b36-ehp-117-716">O&#8217;Brien et al. 2003</xref>; <xref ref-type="bibr" rid="b46-ehp-117-716">Standeven and Wetterhahn 1991</xref>; <xref ref-type="bibr" rid="b52-ehp-117-716">Zhitkovich 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac34" novelty="None" advantage="None"/></s>
          <s sid="163">Cr(III), the final product of intracellular reduction of Cr(VI), has been shown to interact directly with DNA and other macromolecules to induce chromosomal alterations and mutational changes (<xref ref-type="bibr" rid="b36-ehp-117-716">O&#8217;Brien et al. 2003</xref>; <xref ref-type="bibr" rid="b41-ehp-117-716">Quievryn et al. 2006</xref>; <xref ref-type="bibr" rid="b42-ehp-117-716">Reynolds et al. 2007</xref>; <xref ref-type="bibr" rid="b52-ehp-117-716">Zhitkovich 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac35" novelty="None" advantage="None"/></s>
          <s sid="164">DNA adducts, DNA&#8211;protein cross-links, and DNA interstrand cross-links have all been identified as products of Cr(III)&#8211;DNA interactions.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac36" novelty="None" advantage="None"/></s>
          <s sid="165">The relative contributions of the multiple, complex pathways of chromium-induced genotoxicity continue to be investigated.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot6" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="166">In conclusion, the NTP 2-year study of SDD is the first and only lifetime study that clearly demonstrates the carcinogenicity of Cr(VI) in rats and mice after oral exposure.<CoreSc1 atype="GSC" type="Con" conceptID="Con11" novelty="None" advantage="None"/></s>
          <s sid="167">In addition, the hematology, histologic and tissue distribution data provide evidence of systemic exposure in rats and mice.<CoreSc1 atype="GSC" type="Con" conceptID="Con12" novelty="None" advantage="None"/></s>
        </p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn>
          <p>We thank P. Foster and S. Masten for critical review of the manuscript.</p>
        </fn>
        <fn>
          <p>This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences, under research project 1 Z01 ES045004-11 BB.</p>
        </fn>
      </fn-group>
      <ref-list>
        <title>References</title>
        <ref id="b1-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">Agency for Toxic Substances and Disease Registry</collab>
            <year>2000</year>
            <source>Toxicological Profile for Chromium</source>
            <publisher-loc>Atlanta, GA</publisher-loc>
            <publisher-name>Agency for Toxic Substances and Disease Registry</publisher-name>
          </citation>
        </ref>
        <ref id="b2-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bailer</surname>
                <given-names>AJ</given-names>
              </name>
              <name name-style="western">
                <surname>Portier</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <year>1988</year>
            <article-title>Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples</article-title>
            <source>Biometrics</source>
            <volume>44</volume>
            <fpage>417</fpage>
            <lpage>431</lpage>
          </citation>
        </ref>
        <ref id="b3-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Beaumont</surname>
                <given-names>JJ</given-names>
              </name>
              <name name-style="western">
                <surname>Sedman</surname>
                <given-names>RM</given-names>
              </name>
              <name name-style="western">
                <surname>Reynolds</surname>
                <given-names>SD</given-names>
              </name>
              <name name-style="western">
                <surname>Sherman</surname>
                <given-names>CD</given-names>
              </name>
              <name name-style="western">
                <surname>Li</surname>
                <given-names>LH</given-names>
              </name>
              <name name-style="western">
                <surname>Howd</surname>
                <given-names>RA</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2008</year>
            <article-title>Cancer mortality in a Chinese population exposed to hexavalent chromium in drinking water</article-title>
            <source>Epidemiology</source>
            <volume>19</volume>
            <fpage>12</fpage>
            <lpage>23</lpage>
          </citation>
        </ref>
        <ref id="b4-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Boorman</surname>
                <given-names>GA</given-names>
              </name>
              <name name-style="western">
                <surname>Montgomery</surname>
                <given-names>CA</given-names>
                <suffix>Jr</suffix>
              </name>
              <name name-style="western">
                <surname>Eustis</surname>
                <given-names>SL</given-names>
              </name>
              <name name-style="western">
                <surname>Wolfe</surname>
                <given-names>MJ</given-names>
              </name>
              <name name-style="western">
                <surname>McConnell</surname>
                <given-names>EE</given-names>
              </name>
              <name name-style="western">
                <surname>Hardisty</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <person-group person-group-type="editor">
              <name name-style="western">
                <surname>Milman</surname>
                <given-names>HA</given-names>
              </name>
              <name name-style="western">
                <surname>Weisburger</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <year>1985</year>
            <article-title>Quality assurance in pathology for rodent carcinogenicity studies</article-title>
            <source>Handbook of Carcinogen Testing</source>
            <publisher-loc>Park Ridge, NJ</publisher-loc>
            <publisher-name>Noyes Publications</publisher-name>
            <fpage>345</fpage>
            <lpage>357</lpage>
          </citation>
        </ref>
        <ref id="b5-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Borneff</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Engelhardt</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Griem</surname>
                <given-names>W</given-names>
              </name>
              <name name-style="western">
                <surname>Kunte</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Reichert</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <year>1968</year>
            <article-title>Carcinogens in water and soil. XXII. Experiment with 3,4-benzopyrene and potassium chromate in mice drink [in German]</article-title>
            <source>Arch Hyg Bakteriol</source>
            <volume>152</volume>
            <fpage>45</fpage>
            <lpage>53</lpage>
          </citation>
        </ref>
        <ref id="b6-ehp-117-716">
          <citation citation-type="web" xlink:type="simple">
            <collab xlink:type="simple">CDPH (California Department of Public Health)</collab>
            <year>2007a</year>
            <source>Chromium-6 in Drinking Water Standard: Sampling Results</source>
            <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://ww2.cdph.ca.gov/certlic/drinkingwater/Pages/Chromium6sampling.aspx" xlink:type="simple">http://ww2.cdph.ca.gov/certlic/drinkingwater/Pages/Chromium6sampling.aspx</ext-link></comment>
            <access-date>[accessed 10 November 2008]</access-date>
          </citation>
        </ref>
        <ref id="b7-ehp-117-716">
          <citation citation-type="web" xlink:type="simple">
            <collab xlink:type="simple">CDPH (California Department of Public Health)</collab>
            <year>2007b</year>
            <source>Chromium-6 in Drinking Water: Regulation Update</source>
            <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://ww2.cdph.ca.gov/certlic/drinkingwater/Pages/Chromium6.aspx" xlink:type="simple">http://ww2.cdph.ca.gov/certlic/drinkingwater/Pages/Chromium6.aspx</ext-link></comment>
            <access-date>[accessed 10 November 2008]</access-date>
          </citation>
        </ref>
        <ref id="b8-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Chorvatovicova</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Ginter</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Kosinova</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Zloch</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <year>1991</year>
            <article-title>Effect of vitamins C and E on toxicity and mutagenicity of hexa valent chromium in rat and guinea pig</article-title>
            <source>Mutat Res</source>
            <volume>262</volume>
            <fpage>41</fpage>
            <lpage>46</lpage>
          </citation>
        </ref>
        <ref id="b9-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cohen</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Kargacin</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Klein</surname>
                <given-names>CB</given-names>
              </name>
              <name name-style="western">
                <surname>Costa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <year>1993</year>
            <article-title>Mechanisms of chromium carcinogenicity and toxicity</article-title>
            <source>Crit Rev Toxicol</source>
            <volume>23</volume>
            <fpage>255</fpage>
            <lpage>281</lpage>
          </citation>
        </ref>
        <ref id="b10-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Costa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <year>1997</year>
            <article-title>Toxicity and carcinogenicity of Cr(VI) in animal models and humans</article-title>
            <source>Crit Rev Toxicol</source>
            <volume>27</volume>
            <fpage>431</fpage>
            <lpage>442</lpage>
          </citation>
        </ref>
        <ref id="b11-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Costa</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Klein</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Toxicity and carcinogenicity of chromium compounds in humans</article-title>
            <source>Crit Rev Toxicol</source>
            <volume>36</volume>
            <fpage>155</fpage>
            <lpage>163</lpage>
          </citation>
        </ref>
        <ref id="b12-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cox</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <year>1972</year>
            <article-title>Regression models and life-tables</article-title>
            <source>J R Stat Soc</source>
            <volume>B34</volume>
            <fpage>187</fpage>
            <lpage>220</lpage>
          </citation>
        </ref>
        <ref id="b13-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>De Flora</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Threshold mechanisms and site specificity in chromium(VI) carcinogenesis</article-title>
            <source>Carcinogenesis</source>
            <volume>21</volume>
            <fpage>533</fpage>
            <lpage>541</lpage>
          </citation>
        </ref>
        <ref id="b14-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>De Flora</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Bagnasco</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Serra</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Zanacchi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <year>1990</year>
            <article-title>Genotoxicity of chromium compounds. A review</article-title>
            <source>Mutat Res</source>
            <volume>238</volume>
            <fpage>99</fpage>
            <lpage>172</lpage>
          </citation>
        </ref>
        <ref id="b15-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>De Flora</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Camoirano</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Bagnasco</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Bennicilli</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Corbett</surname>
                <given-names>GE</given-names>
              </name>
              <name name-style="western">
                <surname>Kerger</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <year>1997</year>
            <article-title>Estimates of the chromium (VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity</article-title>
            <source>Carcinogenesis</source>
            <volume>18</volume>
            <fpage>531</fpage>
            <lpage>537</lpage>
          </citation>
        </ref>
        <ref id="b16-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>De Flora</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>D&#8217;Agostini</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Balansky</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Micale</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Baluce</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Izzotti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>2008</year>
            <article-title>Lack of genotoxic effects in hematopoietic and gastrointestinal cells of mice receiving chromium(VI) with the drinking water</article-title>
            <source>Mutat Res</source>
            <volume>659</volume>
            <fpage>60</fpage>
            <lpage>67</lpage>
          </citation>
        </ref>
        <ref id="b17-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Dixon</surname>
                <given-names>WJ</given-names>
              </name>
              <name name-style="western">
                <surname>Massey</surname>
                <given-names>FJ</given-names>
                <suffix>Jr</suffix>
              </name>
            </person-group>
            <year>1957</year>
            <source>Introduction to Statistical Analysis</source>
            <edition>2nd ed</edition>
            <publisher-loc>New York</publisher-loc>
            <publisher-name>McGraw-Hill</publisher-name>
          </citation>
        </ref>
        <ref id="b18-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Donaldson</surname>
                <given-names>RM</given-names>
                <suffix>Jr</suffix>
              </name>
              <name name-style="western">
                <surname>Barreras</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <year>1966</year>
            <article-title>Intestinal absorption of trace quantities of chromium</article-title>
            <source>J Lab Clin Med</source>
            <volume>68</volume>
            <fpage>484</fpage>
            <lpage>493</lpage>
          </citation>
        </ref>
        <ref id="b19-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Dunn</surname>
                <given-names>OJ</given-names>
              </name>
            </person-group>
            <year>1964</year>
            <article-title>Multiple comparisons using rank sums</article-title>
            <source>Technometrics</source>
            <volume>6</volume>
            <fpage>241</fpage>
            <lpage>252</lpage>
          </citation>
        </ref>
        <ref id="b20-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Dunnett</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <year>1955</year>
            <article-title>A multiple comparison procedure for comparing several treatments with a control</article-title>
            <source>J Am Stat Assoc</source>
            <volume>50</volume>
            <fpage>1096</fpage>
            <lpage>1121</lpage>
          </citation>
        </ref>
        <ref id="b21-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Febel</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Szegedi</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Huszar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>Absorption of inorganic, trivalent and hexavalent chromium following oral and intrajejunal doses in rats</article-title>
            <source>Acta Vet Hung</source>
            <volume>49</volume>
            <fpage>203</fpage>
            <lpage>209</lpage>
          </citation>
        </ref>
        <ref id="b22-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <collab xlink:type="simple">Food and Drug Administration</collab>
            <year>1987</year>
            <article-title>Good laboratory practice regulations. Final rule. 21 CFR 58</article-title>
            <source>Fed Reg</source>
            <volume>52</volume>
            <issue>172</issue>
            <fpage>33768</fpage>
            <lpage>33782</lpage>
          </citation>
        </ref>
        <ref id="b23-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <collab xlink:type="simple">International Agency for Research on Cancer</collab>
            <year>1990</year>
            <article-title>Chromium</article-title>
            <source>IARC Monogr Eval Carcinog Risks Hum</source>
            <volume>49</volume>
            <fpage>49</fpage>
            <lpage>256</lpage>
          </citation>
        </ref>
        <ref id="b24-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Jonckheere</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <year>1954</year>
            <article-title>A distribution-free <italic>k</italic>-sample test against ordered alternatives</article-title>
            <source>Biometrika</source>
            <volume>41</volume>
            <fpage>133</fpage>
            <lpage>145</lpage>
          </citation>
        </ref>
        <ref id="b25-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kaplan</surname>
                <given-names>EL</given-names>
              </name>
              <name name-style="western">
                <surname>Meier</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <year>1958</year>
            <article-title>Nonparametric estimation from incomplete observations</article-title>
            <source>J Am Stat Assoc</source>
            <volume>53</volume>
            <fpage>457</fpage>
            <lpage>481</lpage>
          </citation>
        </ref>
        <ref id="b26-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Maronpot</surname>
                <given-names>RR</given-names>
              </name>
              <name name-style="western">
                <surname>Boorman</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <year>1982</year>
            <article-title>Interpretation of rodent hepato-cellular proliferative alterations and hepatocellular tumors in chemical safety assessment</article-title>
            <source>Toxicol Pathol</source>
            <volume>10</volume>
            <fpage>71</fpage>
            <lpage>80</lpage>
          </citation>
        </ref>
        <ref id="b27-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>McConnell</surname>
                <given-names>EE</given-names>
              </name>
              <name name-style="western">
                <surname>Solleveld</surname>
                <given-names>HA</given-names>
              </name>
              <name name-style="western">
                <surname>Swenberg</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Boorman</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <year>1986</year>
            <article-title>Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>76</volume>
            <fpage>283</fpage>
            <lpage>289</lpage>
          </citation>
        </ref>
        <ref id="b28-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">National Cancer Institute</collab>
            <year>1977</year>
            <article-title>Bioassay of Captan for Possible Carcinogenicity (CAS No. 133-06-2)</article-title>
            <source>Technical Report 15</source>
            <publisher-loc>Bethesda, MD</publisher-loc>
            <publisher-name>National Cancer Institute</publisher-name>
          </citation>
        </ref>
        <ref id="b29-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">National Research Council</collab>
            <year>1996</year>
            <article-title>Guide for the Care and Use of Laboratory Animals</article-title>
            <publisher-loc>Washington, DC</publisher-loc>
            <publisher-name>National Academies Press</publisher-name>
          </citation>
        </ref>
        <ref id="b30-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Neter</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Kutner</surname>
                <given-names>MH</given-names>
              </name>
              <name name-style="western">
                <surname>Nachtsheim</surname>
                <given-names>CJ</given-names>
              </name>
              <name name-style="western">
                <surname>Wasserman</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <year>1996</year>
            <source>Applied Linear Statistical Models</source>
            <edition>4th ed</edition>
            <publisher-loc>Boston</publisher-loc>
            <publisher-name>WCB McGraw-Hill</publisher-name>
            <fpage>115</fpage>
            <lpage>124</lpage>
          </citation>
        </ref>
        <ref id="b31-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">NTP</collab>
            <year>1993</year>
            <article-title>Toxicology and Carcinogenesis Studies of 1,2,3-Trichloropropane (CAS No 96-18-4) in F344/N Rats and B6C3F<sub>1</sub> Mice (Gavage Studies). TR 384</article-title>
            <publisher-loc>Research Triangle Park, NC</publisher-loc>
            <publisher-name>National Toxicology Program</publisher-name>
          </citation>
        </ref>
        <ref id="b32-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">NTP</collab>
            <year>1998</year>
            <source>Report on Carcinogens</source>
            <edition>8th ed</edition>
            <publisher-loc>Research Triangle Park, NC</publisher-loc>
            <publisher-name>National Toxicology Program</publisher-name>
          </citation>
        </ref>
        <ref id="b33-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">NTP</collab>
            <year>2007</year>
            <article-title>Toxicity Studies of Sodium Dichromate Dihydrate (CAS No 7789-12-0) Administered in Drinking Water to Male and Female F344/N Rats and B6C3F<sub>1</sub> Mice and Male BALB/c and <italic>am3</italic>-C57BL/6 Mice. TOX 72 </article-title>
            <publisher-loc>Research Triangle Park, NC</publisher-loc>
            <publisher-name>National Toxicology Program</publisher-name>
          </citation>
        </ref>
        <ref id="b34-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">NTP</collab>
            <year>2008a</year>
            <article-title>Toxicology and Carcinogenesis Studies of Sodium Dichromate Dihydrate (CAS No 7789-12-0) in F344/N Rats and B6C3F<sub>1</sub> Mice (Drinking Water Studies). TR 546</article-title>
            <publisher-loc>Research Triangle Park, NC</publisher-loc>
            <publisher-name>National Toxicology Program</publisher-name>
          </citation>
        </ref>
        <ref id="b35-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">NTP</collab>
            <year>2008b</year>
            <article-title>Toxicology and Carcinogenesis Studies of Chromium Picolinate Monohydrate (CAS No 27882-76-4) in F344/N Rats and B6C3F<sub>1</sub> Mice (Feed Studies) [draft]. TR 556</article-title>
            <publisher-loc>Research Triangle Park, NC</publisher-loc>
            <publisher-name>National Toxicology Program</publisher-name>
          </citation>
        </ref>
        <ref id="b36-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>O&#8217;Brien</surname>
                <given-names>TJ</given-names>
              </name>
              <name name-style="western">
                <surname>Ceryak</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Patierno</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Complexities of chromium carcinogenesis: Role of cellular response, repair, and recovery mechanisms</article-title>
            <source>Mutat Res</source>
            <volume>533</volume>
            <fpage>3</fpage>
            <lpage>36</lpage>
          </citation>
        </ref>
        <ref id="b37-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Pellerin</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Booker</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Reflections on hexavalent chromium: health hazards of an industrial heavyweight</article-title>
            <source>Environ Health Perspect</source>
            <volume>108</volume>
            <fpage>A402</fpage>
            <lpage>A407</lpage>
          </citation>
        </ref>
        <ref id="b38-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Piegorsch</surname>
                <given-names>WW</given-names>
              </name>
              <name name-style="western">
                <surname>Bailer</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <year>1997</year>
            <source>Statistics for Environmental Biology and Toxicology </source>
            <publisher-loc>London</publisher-loc>
            <publisher-name>Chapman and Hall</publisher-name>
          </citation>
        </ref>
        <ref id="b39-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Portier</surname>
                <given-names>CJ</given-names>
              </name>
              <name name-style="western">
                <surname>Bailer</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <year>1989</year>
            <article-title>Testing for increased carcinogenicity using a survival-adjusted quantal response test</article-title>
            <source>Fundam Appl Toxicol</source>
            <volume>12</volume>
            <fpage>731</fpage>
            <lpage>737</lpage>
          </citation>
        </ref>
        <ref id="b40-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Proctor</surname>
                <given-names>DM</given-names>
              </name>
              <name name-style="western">
                <surname>Otani</surname>
                <given-names>JM</given-names>
              </name>
              <name name-style="western">
                <surname>Finley</surname>
                <given-names>BL</given-names>
              </name>
              <name name-style="western">
                <surname>Paustenbach</surname>
                <given-names>DJ</given-names>
              </name>
              <name name-style="western">
                <surname>Bland</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Speizer</surname>
                <given-names>N</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2002</year>
            <article-title>Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review</article-title>
            <source>J Toxicol Environ Health A</source>
            <volume>65</volume>
            <fpage>701</fpage>
            <lpage>746</lpage>
          </citation>
        </ref>
        <ref id="b41-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Quievryn</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Messer</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Zhitkovich</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate</article-title>
            <source>Carcinogenesis</source>
            <volume>27</volume>
            <fpage>2316</fpage>
            <lpage>2321</lpage>
          </citation>
        </ref>
        <ref id="b42-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Reynolds</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Stoddard</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Bespalov</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Zhitkovich</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair</article-title>
            <source>Nucleic Acids Res</source>
            <volume>35</volume>
            <fpage>465</fpage>
            <lpage>476</lpage>
          </citation>
        </ref>
        <ref id="b43-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sedman</surname>
                <given-names>RM</given-names>
              </name>
              <name name-style="western">
                <surname>Beaumont</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>McDonald</surname>
                <given-names>TA</given-names>
              </name>
              <name name-style="western">
                <surname>Reynolds</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Krowech</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Howd</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Review of the evidence regarding the carcinogenicity of hexavalent chromium in drinking water</article-title>
            <source>J Environ Sci Health C</source>
            <volume>24</volume>
            <fpage>155</fpage>
            <lpage>182</lpage>
          </citation>
        </ref>
        <ref id="b44-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Shackelford</surname>
                <given-names>CC</given-names>
              </name>
              <name name-style="western">
                <surname>Elwell</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <person-group person-group-type="editor">
              <name name-style="western">
                <surname>Maronpot</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <year>1999</year>
            <article-title>Small and large intestine, and mesentery</article-title>
            <source>Pathology of the Mouse</source>
            <publisher-loc>Vienna, IL</publisher-loc>
            <publisher-name>Cache River Press</publisher-name>
            <fpage>81</fpage>
            <lpage>118</lpage>
          </citation>
        </ref>
        <ref id="b45-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Shirley</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <year>1977</year>
            <article-title>A non-parametric equivalent of Williams&#8217; test for contrasting increasing dose levels of a treatment</article-title>
            <source>Biometrics</source>
            <volume>33</volume>
            <fpage>386</fpage>
            <lpage>389</lpage>
          </citation>
        </ref>
        <ref id="b46-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Standeven</surname>
                <given-names>AM</given-names>
              </name>
              <name name-style="western">
                <surname>Wetterhahn</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <year>1991</year>
            <article-title>Is there a role for reactive oxygen species in the mechanism of chromium(VI) carcino-genesis?</article-title>
            <source>Chem Res Toxicol</source>
            <volume>4</volume>
            <fpage>616</fpage>
            <lpage>625</lpage>
          </citation>
        </ref>
        <ref id="b47-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Tarone</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <year>1975</year>
            <article-title>Tests for trend in life table analysis</article-title>
            <source>Biometrika</source>
            <volume>62</volume>
            <fpage>679</fpage>
            <lpage>682</lpage>
          </citation>
        </ref>
        <ref id="b48-ehp-117-716">
          <citation citation-type="web" xlink:type="simple">
            <collab xlink:type="simple">U.S. EPA (Environmental Protection Agency)</collab>
            <year>2003</year>
            <source>National primary drinking water regulations 40CFR14162 </source>
            <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://edocket.access.gpo.gov/cfr_2003/julqtr/40cfr141.62.htm" xlink:type="simple">http://edocket.access.gpo.gov/cfr_2003/julqtr/40cfr141.62.htm</ext-link></comment>
            <access-date>[accessed 3 April 2009]</access-date>
          </citation>
        </ref>
        <ref id="b49-ehp-117-716">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">U.S. EPA</collab>
            <year>1998</year>
            <article-title>Toxicological Review of Hexavalent Chromium (CAS No 18540-29-9)</article-title>
            <source>Support of Summary Information on the Integrated Risk Information System (IRIS)</source>
            <publisher-loc>Washington DC</publisher-loc>
            <publisher-name>U.S. Environmental Protection Agency</publisher-name>
          </citation>
        </ref>
        <ref id="b50-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Williams</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <year>1986</year>
            <article-title>A note on Shirley&#8217;s nonparametric test for comparing several dose levels with a zero-dose control</article-title>
            <source>Biometrics</source>
            <volume>42</volume>
            <fpage>183</fpage>
            <lpage>186</lpage>
          </citation>
        </ref>
        <ref id="b51-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Zhang</surname>
                <given-names>JD</given-names>
              </name>
              <name name-style="western">
                <surname>Li</surname>
                <given-names>XL</given-names>
              </name>
            </person-group>
            <year>1987</year>
            <article-title>Chromium pollution of soil and water in Jinzhou [in Chinese]</article-title>
            <source>Zhonghua Yu Fang Yi Xue Za Zhi</source>
            <volume>21</volume>
            <fpage>262</fpage>
            <lpage>264</lpage>
          </citation>
        </ref>
        <ref id="b52-ehp-117-716">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Zhitkovich</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Importance of chromium&#8212;DNA adducts in mutagenicity and toxicity of chromium (VI)</article-title>
            <source>Chem Res Toxicol</source>
            <volume>18</volume>
            <fpage>3</fpage>
            <lpage>9</lpage>
          </citation>
        </ref>
      </ref-list>
    </back>
  </article>
</PAPER>